"...the Xpert HIV-1 Viral Load (Cepheid) cartridge was launched in 2014, as a potential point-of-care, rapid viral load assay. However, before the Xpert HIV-1 Viral Load cartridge can be clinically used in India, validation is essential. In March, 2017, Xpert HIV-1 Viral Load cartridges were approved by the Indian regulatory agency, but there are no published data on test performance in India. We validated a research use only version of this new HIV-1 viral load assay in India, in a hospital setting where GeneXpert was already used for tuberculosis testing."
To read the full correspondence published in The Lancet Global Health, click here.
Source: The Lancet Global Health